AI in pediatric cancer recurrence is transforming how doctors identify the risk of relapse in young patients battling brain tumors.A recent study revealed that an AI-driven tool, utilizing advanced machine learning techniques, significantly outperformed traditional methods, providing a clearer picture of relapse risk in pediatric glioma cases.